PACB241220C1500
- 0.35
- +0.01+2.94%
Pacific Biosciences of California Newsroom
Pacific Biosciences of California, Inc. (PACB): Among the Best Genomics Stocks to Buy Right Now
Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness
ARKK's Holdings Ranked by SA Quant Grades
Pacific Biosciences of California | 10-Q: Q3 2024 Earnings Report
Pacific Biosciences of California Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Pacific Biosciences Price Target Announced at $2.00/Share by UBS
Express News | Pacific Biosciences of California Inc : UBS Cuts to Neutral From Buy
Scotiabank Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Cuts Target Price to $6
Pacific Biosciences Is Maintained at Neutral by Piper Sandler
Pacific Biosciences Analyst Ratings
Piper Sandler Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Raises Target Price to $2.5
Earnings Update: Pacific Biosciences of California, Inc. (NASDAQ:PACB) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
PacBio to Present at Upcoming Investor Conferences
PACB Stock Falls Despite Q3 Earnings Beat, Revenues Decline Y/Y
Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session
TD Cowen Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Raises Target Price to $4
Barclays Reaffirms Their Hold Rating on Pacific Biosciences (PACB)
Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Call Highlights: Navigating ...
Pacific Biosciences of California, Inc. (PACB) Q3 2024 Earnings Call Transcript Summary
Pacific Biosciences Of California, Inc. Q3 Loss Decreases, Beats Estimates